Gene · 644079
Papers2,404
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,404
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38156758 | PubTator, text mining | PubMed |
| Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide. | Biomed Pharmacother | 2024 | 38141281 | PubTator, text mining | PubMed |
| Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1. | Int Immunopharmacol | 2024 | 38134594 | PubTator, text mining | PubMed |
| Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S. | Clin Pharmacol Ther | 2024 | 38124355 | PubTator, text mining | PubMed |
| Maribavir: Mechanism of action, clinical, and translational science. | Clin Transl Sci | 2024 | 38071422 | PubTator, text mining | PubMed |
| Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor Approach. | Clin Pharmacol Ther | 2024 | 38037845 | PubTator, text mining | PubMed |
| Bidirectional pharmacokinetic drug interactions between olaparib and metformin. | Cancer Chemother Pharmacol | 2024 | 37815561 | PubTator, text mining | PubMed |
| Venetoclax dose adjustment due to drug-drug interactions: a case report and literature review. | Anticancer Drugs | 2024 | 37615531 | PubTator, text mining | PubMed |
| Transport and interaction mechanism of four pesticide residues from Chaenomeles speciosa across Caco-2 cells. | Food Chem | 2024 | 37591142 | PubTator, text mining | PubMed |
| Comparative Anticancer Potential of Green Tea Extract and Epigallocatechin-3-gallate on Breast Cancer Spheroids. | Foods | 2023 | 38201092 | PubTator, text mining | PubMed |
| Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment. | Oncol Res | 2023 | 38188681 | PubTator, text mining | PubMed |
| The role of the C. albicans transcriptional repressor NRG1 during filamentation and disseminated candidiasis is strain-dependent. | bioRxiv | 2023 | 38168187 | PubTator, text mining | PubMed |
| Drug Delivery to the Brain: Recent Advances and Unmet Challenges. | Pharmaceutics | 2023 | 38139999 | PubTator, text mining | PubMed |
| Role of Mangiferin in Management of Cancers through Modulation of Signal Transduction Pathways. | Biomedicines | 2023 | 38137424 | PubTator, text mining | PubMed |
| PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma. | Cancers (Basel) | 2023 | 38136401 | PubTator, text mining | PubMed |
| Re-evaluation of erythritol (E 968) as a food additive. | EFSA J | 2023 | 38125972 | PubTator, text mining | PubMed |
Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings. | Iran J Pathol | 2023 | 38098967 | PubTator, text mining | PubMed |
| Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research. | Front Pharmacol | 2023 | 38094891 | PubTator, text mining | PubMed |
| The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications. | Front Immunol | 2023 | 38094306 | PubTator, text mining | PubMed |
| DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1. | Sci Transl Med | 2023 | 38091406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/644079/papers?page=9